000			01524 a2200445 4500
005			20250513034851.0
264		0	_c19950914
008			199509s 0 0 eng d
022			_a0004-3591
024	7		_a10.1002/art.1780380812 _2doi
040			_aNLM _beng _cNLM
100	1		_avan der Lubbe, P A
245	0	0	_aA randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. _h[electronic resource]
260			_bArthritis and rheumatism _cAug 1995
300			_a1097-106 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aArthritis, Rheumatoid _ximmunology
650	0	4	_aBlood Cell Count
650	0	4	_aCD4 Antigens _ximmunology
650	0	4	_aCD4-Positive T-Lymphocytes _xcytology
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPain Measurement
650	0	4	_aPlacebos
650	0	4	_aTime Factors
700	1		_aDijkmans, B A
700	1		_aMarkusse, H M
700	1		_aNässander, U
700	1		_aBreedveld, F C
773	0		_tArthritis and rheumatism _gvol. 38 _gno. 8 _gp. 1097-106
856	4	0	_uhttps://doi.org/10.1002/art.1780380812 _zAvailable from publisher's website
999			_c7639237 _d7639237